Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs

Journal of Neuro-Oncology

Volumn 107, Issue 3, 2012, Pages 457-462

  Fu, Yuejun ^a   An, Na ^a   Li, Ke ^b   Zheng, Yali ^a   Liang, Aihua ^a  

^a SHANXI UNIVERSITY   (China)

^b Zhejiang Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Chlorotoxin (CTX); Glioma; Nanoparticles

Indexed keywords

CHITOSAN; CHLORIDE CHANNEL BLOCKING AGENT; CHLOROTOXIN; CHLOROTOXIN CONJUGATED NANOPARTICLE; ENZYME INHIBITOR; GELATINASE A; IODINE 131; IRON OXIDE; LANTHANIDE; MACROGOL; MAGNETIC AND FLUORESCENT SILICAL NANOPARTICLE CHLOROTOXIN; NANOPARTICLE; NANOPARTICLE AF 647 CHLOROTOXIN DNA; NANOPARTICLE CHLOROTOXIN ALEXA FLUORO 680 FLUOROCHROME; NANOPARTICLE CHLOROTOXIN CHITOSAN CY5.5; NANOPARTICLE CHLOROTOXIN CY5.5; NANOPARTICLE COATED WITH COPOLYMER CY5.5 CHLOROTOXIN; NANOPARTICLE DNA CHLOROTOXIN; NANOPARTICLE HIGHLY AMINE BLOCKED POLYETHYLENEIMINE; NANOPARTICLE HIGHLY AMINE BLOCKED POLYETHYLENEIMINE SMALL INTERFERING RNA CHLOROTOXIN; NANOPARTICLE METHOTREXATE CHLOROTOXIN; NANOPARTICLE SMALL INTERFERING RNA CHLOROTOXIN; POLYETHYLENEIMINE; POLYVINYL ALCOHOL; RARE EARTH UPCONVERSION CHLOROTOXIN; SCORPION VENOM; TMX 601; UNCLASSIFIED DRUG;

BINDING AFFINITY; CANCER CHEMOTHERAPY; CELL SURFACE; DRUG EFFICACY; GLIOMA; HUMAN; NONHUMAN; REVIEW; TUMOR CELL; ANIMAL; BRAIN TUMOR; DRUG DELIVERY SYSTEM; METHODOLOGY;

ANIMALS; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; GLIOMA; HUMANS; NANOPARTICLES; SCORPION VENOMS;

EID: 84864361918     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0763-6     Document Type: Review

References (59)

1. Whitesides GM (2003) The 'right' size in nanobiotechnology. Nat Biotechnol 21:1161-1165
2. Cooper DR, Nadeau JL (2009) Nanotechnology for in vitro neuroscience. Nanoscale 1:183-200
3. Weissleder R (2006) Molecular imaging in cancer. Science 312:1168-1171
4. Veiseh O, Gunn JW, Kievit FM, Sun C, Fang C, Lee JS, Zhang M (2009) Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 5:256-264
5. Veiseh O, Kievit FM, Gunn JW, Ratner BD, Zhang M (2009) A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells. Biomaterials 30:649-657
6. Veiseh O, Sun C, Fang C, Bhattarai N, Gunn J, Kievit F, Du K, Pullar B, Lee D, Ellenbogen RG, Olson J, Zhang M (2009) Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 69:6200-6207
7. Butterworth MD, Illum L, Davis SS (2001) Preparation of ultrafine silica- and PEG-coated magnetite particles. Colloids Surf A 179:93-102
8. Sun C, Du K, Fang C, Bhattarai N, Veiseh O, Kievit F, Stephen Z, Lee D, Ellenbogen RG, Ratner B, Zhang MQ (2010) PEGmediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano 4:2402-2410
9. Aina OH, Sroka TC, Chen ML, Lam KS (2002) Therapeutic cancer targeting peptides. Biopolymers 66:184-199
10. Soroceanu L, Gillespie Y, Khazaeli MB, Sontheimer H (1998) Use of chlorotoxin for targeting of primary brain tumors. Cancer Res 58:4871-4879
11. Olsen ML, Schade S, Lyons SA, Amaral MD, Sontheimer H (2003) Expression of voltage-gated chloride channels in human glioma cells. J Neurosci 23:5572-5582
12. Mamelak AN, Rosenfeld S, Bucholz R, Raubitschek A, Nabors LB, Fiveash JB, Shen S, Khazaeli MB, Colcher D, Liu A, Osman M, Guthrie B, Schade-Bijur S, Hablitz DM, Alvarez VL, Gonda MA (2006) Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol 24:3644-3650
13. Deshane J, Garner CC, Sontheimer H (2003) Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278:4135-4144
14. Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, Hackman RC, Ravanpay AC, Stroud MR, Kusuma Y, Hansen SJ, Kwok D, Munoz NM, Sze RW, Grady WM, Greenberg NM, Ellenbogen RG, Olson JM (2007) Tumor paint: a chlorotoxin: Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 67:6882-6888
15. Sun C, Fang C, Stephen Z, Veiseh O, Hansen S, Lee D, Ellenbogen RG, Olson J, Zhang M (2008) Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. Nanomedicine (Lond) 3:495-505
16. Mok H, Veiseh O, Fang C, Kievit FM, Wang FY, Park JO, Zhang M (2010) pH-sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. Mol Pharm 7:1930-1939
17. Yu XF, Sun Z, Li M, Xiang Y, Wang QQ, Tang F, Wu Y, Cao Z, Li WX (2010) Neurotoxin-conjugated up conversion nanoprobes for direct visualization of tumors under near-infrared irradiation. Biomaterials 31:8724-8731
18. Lee MJ, Veiseh O, Bhattarai N, Sun C, Hansen SJ, Ditzler S, Knoblaugh S, Lee D, Ellenbogen R, Zhang M, Olson JM (2010) Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel nonradioactive method. PLoS One 5:e9536
19. Wan J, Meng X, Liu E, Chen K (2010) Incorporation of magnetite nanoparticle clusters in fluorescent silica nanoparticles for high-performance brain tumor delineation. Nanotechnology 21:235104
20. Veiseh O, Kievit FM, Fang C, Mu N, Jana S, Leung MC, Mok H, Ellenbogen RG, Park JO, Zhang M (2010) Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. Biomaterials 31:8032-8042
21. Kievit FM, Veiseh O, Fang C, Bhattarai N, Lee D, Ellenbogen RG, Zhang M (2010) Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma. ACS Nano 4:4587-4594
22. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437-445
23. Sonavane G, Tomoda K, Makino K (2008) Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B 66:274-280
24. Sarin H, Kanevsky AS, Wu H, Brimacombe KR, Fung SH, Sousa AA, Auh S, Wilson CM, Sharma K, Aronova MA, Leapman RD, Griffiths GL, Hall MD (2008) Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med 6:80
25. McNneil SE (2005) Nanotechnology for the Biologist. J Leukocyte Biol 78:585-594
26. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422:37-44
27. Wuister SF, de Mello Donega' C, de Mello Donega' C, Meijerink A (2004) Influence of thiol capping on the exciton luminescence and decay kinetics of CdTe and CdSe quantum dots. J Phys Chem B 108:17393-17397
28. Bridot JL, Faure AC, Laurent S, Rivière C, Billotey C, Hiba B, Janier M, Josserand V, Coll JL, Elst LV, Muller R, Roux S, Perriat P, Tillement O (2007) Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc 129:5076-5084
29. Na HB, Lee JH, An K, Park YI, Park M, Lee IS, Nam DH, Kim ST, Kim SH, Kim SW, Lim KH, Kim KS, Kim SO, Hyeon T (2007) Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl 46:5397-5401
30. Chen F, Zhang M (2009) Multifunctional magnetic nanoparticles for medical imaging applications. J Mater Chem 19:6258-6266
31. Cheon J, Lee JH (2008) Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res 41:1630-1640
32. Gilert A, Machluf M (2010) Nano to micro delivery systems: targeting angiogenesis in brain tumors. J Angiogenes Res 2:20
33. Laurent S, Forge D, Port M, Roch A, Robic C, Vander EL, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064-2110
34. Sheng Y, Liu C, Yuan Y, Tao X, Yang F, Shan X, Zhou H, Xu F (2009) Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water soluble chitosan. Biomaterials 30:2340-2348
35. Mok H, Park JW, Park TG (2008) Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. Bioconiugate Chem 19:797-801
36. Lee JH, Lee K, Moon SH, Lee Y, Park TG, Cheon J (2009) Allin- one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed Engl 48:4174-4179
37. Kievit FM, Veiseh O, Bhattarai N, Fang C, Gunn JW, Lee D, Ellenbogen RG, Olson JM, Zhang M (2009) PEI-PEG-Chitosan copolymer coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection. Adv Funct Mater 19:2244-2251
38. Fang C, Bhattarai N, Sun C, Zhang M (2009) Functionalized nanoparticles with long-term stability in biological media. Small 5:1637-1641
39. Céline B, Laurence P, Christelle L, Pierre F, Catherine P, Brigitte G (2007) Cytotoxicity of polyethyleneimine (PEI), precursor base layer of polyelectrolyte multilayer films. Biomaterials 28:632-640
40. Kumar M, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ (2004) Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104:6017-6084
41. Lippens G, Najib J, Wodak SJ, Tartar A (1995) NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels. Biochemistry 34:13-21
42. Mamelak AN, Jacoby DB (2007) Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Drug Deliv 4:175-186
43. Veiseh O, Sun C, Gunn J, Kohler N, Gabikian P, Lee D, Bhattarai N, Ellenbogen R, Rze R, Hallahan A, Olson J, Zhang M (2005) Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 5:1003-1008
44. Liu M, Li H, Luo G, Liu Q, Wang Y (2008) Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Arch Pharm Res 31:547-554
45. Wu XS, Jian XC, Yin B, He ZJ (2010) Development of the research on the application of chlorotoxin in imaging diagnostics and targeted therapies for tumors. Chin J Cancer 29:626-630
46. McNeish IA, Bell SJ, Lemoine NR (2004) Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes. Gene Ther 11:497-503
47. Li SD, Huang L (2006) Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 13:1313-1319
48. Palmer DH, Young LS, Mautner V (2006) Cancer gene-therapy: clinical trials. Trends Biotechnol 24:76-82
49. Alton E, Ferrari S, Griesenbach U (2007) Progress and prospects: gene therapy clinical trials (part 2). Gene Ther 14:1555-1563
50. Fu YJ, Du J, Yang RJ, Yin LT, Liang AH (2010) Potential adenovirus-mediated gene therapy of glioma cancer. Biotechnol Lett 32:11-18
51. Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo polyethylenimine. Proc Natl Acad Sci USA 92:7297-7301
52. Godbey WT, Wu KK, Mikos AG (1999) Poly(ethylenimine) and its role in gene delivery. J Control Release 60:149-160
53. Kircheis R, Wightman L, Wagner E (2001) Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev 53:341-358
54. Hannon GJ (2002) RNA interference. Nature 418:244-251
55. Dykxhoorn DM, Chowdhury D, Lieberman J (2008) RNA interference and cancer: endogenous pathways and therapeutic approaches. Adv Exp Med Biol 615:299-329
56. Oh YK, Park TG (2009) siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 61:850-862
57. Caruso G, Caffo M, Alafaci C, Raudino G, Cafarella D, Lucerna S, Salpietro FM, Tomasello F (2011) Could nanoparticle systems have a role in the treatment of cerebral gliomas? Nanomedicine. doi:10.1016/j.nano.2011.02.008
58. Giuseppe R, Mariella C, Concetta A, Gerardo C (2011) Nanoparticle- based cerebral drug-delivery systems and antiangiogenic approach in gliomas treatment. Recent Pat Nanotechnol (In press)
59. Mohanraj VJ, Chen Y (2006) Nanoparticles-a review. Trop J Pharm Res 5:561-573